Belluscura is focused on developing oxygen enrichment technologies. Its lead product, X-PLO₂R, is pitched as the world’s first modular portable oxygen concentrator (POC). It received FDA 510(k) clearance in March 2021 and came to the market in September 2021. Early uptake is encouraging, with the company signing five distribution agreements and exceeding its sales volume projections for the year. We expect recent reimbursement approval from the US Centers for Medicare & Medicaid Services (CMS) a ....
18 Jan 2022
Belluscura - Promising portable oxygen supplement device
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Belluscura - Promising portable oxygen supplement device
Belluscura PLC (BELL:LON) | 18.5 0 0.0% | Mkt Cap: 30.4m
- Published:
18 Jan 2022 -
Author:
Jacob Thrane -
Pages:
2
Belluscura is focused on developing oxygen enrichment technologies. Its lead product, X-PLO₂R, is pitched as the world’s first modular portable oxygen concentrator (POC). It received FDA 510(k) clearance in March 2021 and came to the market in September 2021. Early uptake is encouraging, with the company signing five distribution agreements and exceeding its sales volume projections for the year. We expect recent reimbursement approval from the US Centers for Medicare & Medicaid Services (CMS) a ....